IQUR LTD has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United Kingdom. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are WEINER DAVID B, RESPONSIF GMBH and COHEN DAVID I.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United Kingdom | 4 | |
#4 | United States | 4 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Israel | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Electrical machinery and energy | |
#5 | Organic fine chemistry | |
#6 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Whelan Michael Anthony | 17 |
#2 | Field Robert A | 10 |
#3 | Rowlands David J | 8 |
#4 | Ramirez Ceballos Alejandro | 5 |
#5 | Cresente Vincenzo | 3 |
#6 | Cross Richard | 2 |
#7 | Rosenberg William Malcolm | 2 |
#8 | Beales Lucy Phillippa | 2 |
#9 | Crescente Vincenzo | 2 |
#10 | Wynne Graham Michael | 1 |
Publication | Filing date | Title |
---|---|---|
CN107207620A | Vaccine based on hepatitis B core antigen | |
GB201505041D0 | Vaccines based on hepatitis B core antigens | |
EP3004173A1 | Single domain antibody display | |
GB201402890D0 | Vaccines based on hepatitis B Core antigens | |
GB0918679D0 | Influenza vaccine | |
GB0614034D0 | Antiviral compounds | |
EP1802770A2 | Methods for genotyping hcv |